Elevated serum erythropoietin as a marker of renal cell carcinoma in a hemodialysis patient.

1997 ◽  
Vol 30 (2) ◽  
pp. 141-145 ◽  
Author(s):  
Keiko Ohi ◽  
Hiroyasu Yamamoto ◽  
Takashi Shigematsu ◽  
Yoshindo Kawaguchi ◽  
Osamu Sakai ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Hemodialysis Patient ◽  
Elevated Serum ◽  
Serum Erythropoietin

Resection of local recurrence of renal cell carcinoma in a hemodialysis patient 6 years after radical nephrectomy

2004 ◽  
Vol 11 (7) ◽  
pp. 550-552 ◽  
Author(s):  
KYOKO IRIE ◽  
OSAMU ISHIZUKA ◽  
HITOSHI YOKOYAMA ◽  
YOSHIAKI KINEBUCHI ◽  
TOMOYA SATOH ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Local Recurrence ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Radical Nephrectomy ◽  
Hemodialysis Patient

scholarly journals A case of pheochromocytoma of the urinary bladder and renal cell carcinoma in a long-term hemodialysis patient

2009 ◽  
Vol 42 (8) ◽  
pp. 595-599
Author(s):  
Yasuto Yamasaki ◽  
Junichi Watanabe ◽  
Naofumi Sakimura ◽  
Kenichi Miyazaki ◽  
Yoshiaki Muraya ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Urinary Bladder ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Hemodialysis Patient

scholarly journals A hemodialysis patient with simultaneous occurrence of renal cell carcinoma and transitional cell carcinoma in the right kidney

2005 ◽  
Vol 38 (7) ◽  
pp. 1345-1349
Author(s):  
Akira Ishikawa ◽  
Yasushi Kondo ◽  
Haruki Kume ◽  
Hiroshi Yokoyama ◽  
Norio Hanafusa ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Transitional Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Hemodialysis Patient ◽  
Transitional Cell ◽  
Simultaneous Occurrence ◽  
The Right

Successful Response to Nivolumab Plus Ipilimumab Therapy in a Hemodialysis Patient With Metastatic Renal Cell Carcinoma

2021 ◽  
Vol 1 (3) ◽  
pp. 207-211
Author(s):  
HIROSHI MASUDA ◽  
KOSUKE MIKAMI ◽  
KOTARO OTSUKA ◽  
KYOKUSIN HOU ◽  
TAKAHITO SUYAMA ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Hemodialysis Patient ◽  
Pulse Therapy ◽  
Hemodialysis Patients ◽  
Combination Immunotherapy ◽  
Efficacy And Safety ◽  
Steroid Pulse

Background/Aim: There are few reports about the administration of nivolumab plus ipilimumab to hemodialysis patients and their efficacy and safety have not been established yet. Case Report: A 74-year-old male, who was receiving hemodialysis, was presented with metastatic renal cell carcinoma (mRCC). Two years later, more metastases were found, hence, immunotherapy involving nivolumab plus ipilimumab was initiated. After two doses of immunotherapy, interstitial pneumonia was observed. Thus, steroid pulse therapy was administered immediately. Subsequently, computed tomography (CT) findings and symptoms improved markedly. One month later, a CT scan showed a nodular shadow and an air cavity. A fungal infection was strongly suspected, so an antifungal drug was administered. Conclusion: Combination immunotherapy with nivolumab plus ipilimumab was demonstrated to be effective in a hemodialysis patient with mRCC.

Anti-glomerular basement membrane disease and IgA nephropathy in a patient with previous renal cell carcinoma

2021 ◽  
Vol 14 (7) ◽  
pp. e236555
Author(s):  
Candice Khor ◽  
Muh Geot Wong ◽  
Jessica Reagh
Keyword(s):  
Renal Cell Carcinoma ◽  
Basement Membrane ◽  
Cell Carcinoma ◽  
Iga Nephropathy ◽  
Glomerular Basement Membrane ◽  
Renal Cell ◽  
Elevated Serum ◽  
Human Leukocyte ◽  
Hla Typing ◽  
Asian Woman

A 66-year-old Asian woman presented with severe kidney injury, microscopic haematuria and subnephrotic range proteinuria with elevated serum anti-glomerular basement membrane (anti-GBM) titre. She had a history of renal cell carcinoma. Renal biopsy revealed dual pathology with immunofluorescence showing 3+ linear glomerular IgG staining and 3+ IgA mesangial staining. Cellular crescents were present on light microscopy and electron microscopy revealed increased mesangial matrix. She was treated with plasma exchange and immunosuppression and remained in stage 4 chronic kidney disease. This case describes the coexistence of anti-GBM disease and IgA nephropathy, a phenomenon not well described in the literature. The report also explores the association of malignancy and glomerulonephritis as well as the role of genetics and the utility of human leukocyte antigen (HLA) typing in risk stratification.

scholarly journals Metastatic Renal Cell Carcinoma in a Hemodialysis Patient with Acquired Renal Cystic Disease

Nephron ◽  
1989 ◽  
Vol 52 (1) ◽  
pp. 96-97 ◽  
Author(s):  
J. Almirall ◽  
C. Mallofre ◽  
J.M. Campistol ◽  
J. Montoliu ◽  
T. Ribalta ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Hemodialysis Patient ◽  
Cystic Disease ◽  
Renal Cystic Disease ◽  
Acquired Renal Cystic Disease

Usefulness of F-18 FDG-PET in a long-term hemodialysis patient with renal cell carcinoma and pheochromocytoma

2007 ◽  
Vol 21 (4) ◽  
pp. 239-243 ◽  
Author(s):  
Nozomi Ozawa ◽  
Terue Okamura ◽  
Koichi Koyama ◽  
Yoshimasa Hamazawa ◽  
Hideto Senzaki ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Fdg Pet ◽  
Renal Cell ◽  
Hemodialysis Patient
Sign in / Sign up

Export Citation Format

Share Document